N
Nora Rozengurt
Researcher at University of California, Los Angeles
Publications - 40
Citations - 5416
Nora Rozengurt is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Bone marrow & Transplantation. The author has an hindex of 27, co-authored 40 publications receiving 5087 citations.
Papers
More filters
Journal ArticleDOI
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
Shunyou Wang,Jing Gao,Qun-Ying Lei,Nora Rozengurt,Colin Pritchard,Jing Jiao,George Thomas,Gang Li,Pradip Roy-Burman,Peter S. Nelson,Xin Liu,Hong Wu +11 more
TL;DR: Global assessment of molecular changes caused by homozygous Pten deletion identified key genes known to be relevant to human prostate cancer, including those "signature" genes associated with human cancer metastasis.
Journal ArticleDOI
Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee
Scott B. Shappell,George Thomas,Richard L. Roberts,Ron Herbert,Michael Ittmann,Mark A. Rubin,Peter A. Humphrey,John P. Sundberg,Nora Rozengurt,Roberto Barrios,Jerrold M. Ward,Robert D. Cardiff +11 more
TL;DR: It is recommended that investigators use the Bar Harbor Classification system when characterizing new GEM models or when conducting experimental interventions that may alter the phenotype or natural history of lesion progression in existing models.
Journal ArticleDOI
PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms
Daniel J. Freeman,Andrew G. Li,Gang Wei,Heng-Hong Li,Nathalie Kertesz,Ralf Lesche,Andrew D. Whale,Hilda Martinez-Diaz,Nora Rozengurt,Robert D. Cardiff,Xuan Liu,Hong Wu +11 more
TL;DR: This study provides a novel mechanism by which the loss of PTEN can functionally control "two" hits in the course of tumor development by concurrently modulating p53 activity.
Journal ArticleDOI
Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells
S. Vincent Wu,Nora Rozengurt,Moon Hee Yang,Steven H. Young,James Sinnett-Smith,Enrique Rozengurt +5 more
TL;DR: The expression of bitter taste receptors of the T2R family in the mouse and rat gastrointestinal tract is demonstrated using reverse transcriptase–PCR and DNA sequencing, immunohistochemistry, and Western blotting.
Journal ArticleDOI
Classification of Proliferative Pulmonary Lesions of the Mouse: Recommendations of the Mouse Models of Human Cancers Consortium
Alexander Yu. Nikitin,Ana Alcaraz,Miriam R. Anver,Roderick T. Bronson,Robert D. Cardiff,Darlene Dixon,Armando E. Fraire,Edward Gabrielson,William T. Gunning,Diana C. Haines,Matthew H. Kaufman,R. Ilona Linnoila,Robert R. Maronpot,Alan S. Rabson,Robert L. Reddick,Sabine Rehm,Nora Rozengurt,Hildegard M. Schuller,Elena N. Shmidt,William D. Travis,Jerrold M. Ward,Tyler Jacks +21 more
TL;DR: A series of discussions was initiated by a panel of human, veterinary, and experimental pathologists during the Mouse Models of Human Cancers Consortium (NIH/National Cancer Institute) workshop on mouse models of lung cancer, and a new practical classification scheme was recommended that would allow easier comparison between human and mouse lung neoplasms.